CONDITION
Prostatic Hyperplasia
Prostatic hyperplasia refers to enlargement of the prostate gland, which sits just behind the bladder in intact male dogs. This enlargement happens as a normal consequence of hormonal influence over time, and tends to develop gradually in most uncastrated males as they age. The prostate tissue responds to testosterone and related hormones by increasing in size, though the gland remains structurally normal. Owners often notice changes in toileting—straining to pass faeces, ribbon-shaped stools, or occasionally blood in the urine or dripping from the prepuce when no urination is happening. Some dogs show no outward signs at all, and the enlargement is identified during examination for another reason. The size of the prostate does not always correspond to the severity of signs; a moderately enlarged gland may cause significant difficulty, while a larger one may cause none. This page explores what an owner may observe, the hormonal and structural changes occurring in the gland, how prostatic hyperplasia is investigated and distinguished from other prostatic conditions, and the range of approaches available for managing it. These approaches vary in how quickly they work, their permanence, and their suitability depending on whether the dog is used for breeding.
Why this matters now
Prostatic hyperplasia tends to develop in intact male dogs from middle age onwards, typically becoming detectable from around five to six years of age. The condition is driven by cumulative hormonal exposure, so prevalence increases with age—by eight to ten years, most uncastrated males will have some degree of prostatic enlargement, though not all will show clinical signs. While prostatic hyperplasia develops to some degree in most ageing intact male dogs regardless of breed, some breeds carry an elevated risk beyond what age alone explains—Rhodesian Ridgebacks, for example, have been shown to develop the condition more frequently and at an earlier age than breeds such as Labrador Retrievers, reflecting breed-specific differences in prostatic hormone metabolism alongside the general ageing process.
Enlargement of the prostate typically progresses gradually over months to years, with the gland increasing in size in response to ongoing hormonal influence. The rate of progression varies considerably between individuals, and some dogs may develop noticeable signs relatively early whilst others remain asymptomatic despite substantial enlargement. The condition does not resolve spontaneously whilst the dog remains intact, and signs may fluctuate in severity depending on the degree of compression exerted on adjacent structures as the gland continues to grow.
Signals & patterns
Early signals
Ribbon-shaped or flattened stools
The enlarged prostate can press against the rectum as it passes through the pelvic canal, narrowing the space available and causing faeces to emerge in a flattened or ribbon-like form. This change in stool shape may be subtle at first and can occur without any straining or discomfort.
Mild straining during defaecation
Pressure from the prostate on the rectum may cause the dog to adopt a prolonged posture or strain gently when passing faeces, even when the stool itself is soft. This is distinct from the straining seen with constipation, as the difficulty relates to mechanical compression rather than stool consistency.
Occasional blood drips from the prepuce
Fresh blood may appear at the tip of the prepuce between urinations, often noticed as small spots on the floor or bedding. This bleeding typically originates from small, fragile blood vessels within the enlarged prostate and can occur intermittently without any other overt signs.
Blood-tinged urine
Urine may appear pink, red, or contain visible streaks of blood, reflecting haemorrhage from the prostate into the urethra. The blood is often most noticeable at the start or end of urination, and the amount can vary from faint discolouration to more obvious contamination.
Later signals
Persistent straining with little or no stool passed
As the prostate enlarges further, compression of the rectum can become more pronounced, leading to repeated, effortful attempts to defaecate with minimal output. This pattern can be distressing and may be mistaken for severe constipation, though the underlying issue is mechanical obstruction rather than hard faeces.
Difficulty or discomfort when urinating
In some cases, significant prostatic enlargement can affect the urethra, leading to a weaker urine stream, prolonged posturing, or apparent discomfort during urination. These signs are less common than defaecatory changes but may emerge if the gland encroaches on the urethral passage.
Recurrent urinary tract infections
An enlarged prostate can alter normal urine flow and drainage, creating conditions that favour bacterial colonisation. Owners may notice increased frequency of urination, discomfort, or persistent blood in the urine, and infections may recur despite treatment if the underlying prostatic enlargement is not addressed.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a history of the signs observed and a physical examination, which may include rectal palpation to assess the size, symmetry, and texture of the prostate. The gland is usually within reach through the rectal wall in most dogs, though in smaller breeds or if the gland is very large, it may sit further forward. If prostatic enlargement is suspected, imaging and sampling techniques help to distinguish benign hyperplasia from other prostatic conditions such as infection, cyst formation, or neoplasia, though no single test provides a definitive answer on its own.
Physical examination and rectal palpation
Radiography
Ultrasonography
Cytology or biopsy
Urinalysis and urine culture
Options & trade-offs
Management of prostatic hyperplasia usually involves addressing the hormonal drive behind the enlargement, though the approach chosen depends on the severity of signs, the dog's role (including whether breeding is planned), and the owner's preferences. Some approaches work within days, others over weeks, and some are permanent whilst others require ongoing treatment. Different combinations suit different households, and the choice often involves weighing speed of effect against permanence and other considerations.
Castration
Surgical removal of the testes eliminates the primary source of testosterone, leading to gradual reduction in prostate size over the following weeks to months. The gland typically shrinks to around half its enlarged size within a few weeks, and signs related to compression tend to resolve as this occurs. Castration is a single procedure with permanent hormonal effects.
Trade-offs: The approach is irreversible and ends any possibility of natural breeding. Some owners are reluctant to castrate for personal, cultural, or breeding-related reasons. The surgery itself carries the usual risks associated with general anaesthesia and soft-tissue surgery, though these are generally low in otherwise healthy dogs.
Medical suppression with osaterone acetate
Osaterone is an anti-androgen medication given as a daily oral tablet for seven days, which blocks the action of testosterone and dihydrotestosterone at the level of the prostate. It tends to reduce gland size and associated signs within a few weeks, and effects are reversible if treatment is stopped. Repeat dosing may be needed to maintain the effect, particularly in dogs where castration is not an option.
Trade-offs: The medication does not eliminate testosterone production, so effects on libido and fertility may be variable and the gland may re-enlarge if treatment is discontinued. Ongoing cost and the need for veterinary visits for administration may be considerations for some owners. Response can vary between individuals.
Medical suppression with deslorelin implant
Deslorelin is a slow-release implant that initially stimulates, then suppresses, the hormonal axis controlling testosterone production. After an initial rise in hormone levels over the first week or two, testosterone production falls and the prostate begins to shrink. The effect lasts several months to over a year depending on the dose, and is reversible once the implant is exhausted.
Trade-offs: The temporary increase in testosterone shortly after implant placement can transiently worsen signs in some dogs before improvement occurs. Duration of effect varies, and the implant may need replacing periodically. Fertility typically returns once the implant's effect wanes, though the time course can be unpredictable.
Finasteride
Finasteride inhibits the enzyme that converts testosterone to dihydrotestosterone within the prostate, reducing the hormonal drive for gland growth. It is given daily by mouth and tends to reduce prostate size gradually over weeks to months. Testosterone levels in the bloodstream remain normal, so effects on libido and fertility are usually minimal.
Trade-offs: The medication requires daily administration and ongoing cost, and the degree of size reduction may be less pronounced than with castration or anti-androgen treatment. Response varies, and some dogs show little benefit. The drug can be absorbed through skin contact, so handling precautions are needed in households with pregnant women.
Monitoring without intervention
In dogs with minimal or no clinical signs, observation over time may be a reasonable approach, particularly if the owner is weighing other considerations or if the dog is elderly with limited life expectancy. The gland may remain stable or continue to enlarge gradually, and intervention can be introduced if signs develop or worsen.
Trade-offs: This approach does not address the underlying hormonal drive, so progression is likely in most cases. Signs may emerge or worsen unpredictably, and delaying intervention does not reduce the options available later, though owners may find it harder to judge when a change in approach is warranted.
Common misconceptions
"Castration will make my dog gain weight or change his personality."
Changes in energy requirements after castration can lead to weight gain if food intake is not adjusted, but this is manageable through portion control and activity. Personality changes are usually subtle and relate to reductions in hormone-driven behaviours such as roaming or mounting; core temperament tends to remain stable. Many owners report no noticeable change in day-to-day behaviour beyond a reduction in sexually motivated actions.
"If my dog is not showing any signs, his prostate is fine and does not need checking."
Prostatic hyperplasia often develops without outward signs, particularly in the early stages, and some dogs tolerate considerable enlargement without difficulty in toileting or other visible changes. The absence of signs does not mean the gland is not enlarged, and findings during routine examination or imaging for other reasons may reveal significant change. The clinical relevance depends on the degree of enlargement and the individual dog's anatomy.
"Once the prostate starts to shrink after treatment, the problem is cured permanently."
Prostate size reduction following castration is typically permanent because the hormonal drive is removed, but medical treatments such as osaterone, deslorelin, or finasteride require ongoing or repeat administration to maintain their effect. If medical suppression is stopped, testosterone influence usually resumes and the gland can re-enlarge over time. The durability of response depends on the approach chosen and whether it is sustained.
Related conditions
Testicular Tumours
Testicular tumours, particularly Sertoli cell tumours, can produce hormones that influence the prostate in ways that overlap with the hormonal drivers of prostatic hyperplasia. Both conditions occur in intact male dogs and may be identified during investigation of similar signs, such as blood in the urine or difficulty with defecation.
Sertoli Cell Tumour
Sertoli cell tumours often secrete oestrogen, which can affect prostatic tissue and may contribute to or complicate prostatic enlargement. The hormonal influence from such tumours can produce signs that resemble or coexist with those of benign prostatic hyperplasia, and both may be considered when investigating an intact male dog with urogenital or toileting changes.
Constipation and Megacolon
Constipation and megacolon can develop when an enlarged prostate presses on the rectum, narrowing the space through which faeces must pass. Straining to defecate and ribbon-shaped stools are signs common to both conditions, and distinguishing between them often requires examination of the prostate itself.
Urinary Tract Infection in Dogs
An enlarged prostate can alter the anatomy around the bladder and urethra in ways that may make urinary tract infections more likely, and infection can complicate the interpretation of signs such as blood in the urine or straining. Both conditions may be present in the same dog, and investigation often considers them together.
Pyelonephritis
Prostatic changes that affect urine flow or bladder emptying can, in some cases, create conditions that allow bacteria to ascend the urinary tract and reach the kidneys. Pyelonephritis and prostatic disease may both contribute to signs such as blood in the urine or difficulty urinating, and investigation may explore both possibilities.
Prostatic hyperplasia sits within a broader group of prostatic conditions that can overlap in presentation, including prostatitis, prostatic cysts, and neoplasia, each with different implications and management paths. Understanding the hormonal and structural changes that underlie hyperplasia may also inform conversations about other hormone-related conditions in intact male dogs, or about the timing and rationale for neutering in individual circumstances. Patterns observed at home—such as the character of straining, the appearance of any blood, or changes in urination—can be useful detail when discussing findings and options.